Refractory inflammatory bowel disease-could it be an irritable bowel?
- PMID: 22965430
- DOI: 10.1038/nrgastro.2012.173
Refractory inflammatory bowel disease-could it be an irritable bowel?
Abstract
Patients with IBD who are apparently in remission-as indicated by normal blood tests, endoscopic findings and ultrasonography results-often continue to experience symptoms. Furthermore, despite these negative findings, there is a temptation to increase their anti-inflammatory medication in the hope that this approach would lead to some improvement. However, this strategy often seems to fail and can sometimes lead to adverse events. Consequently, when evidence of continuing inflammatory activity is lacking it might be appropriate to consider the possibility of co-existent IBS in these patients and to treat them for this condition. Dietary manipulation, antispasmodic agents, antidepressants (especially of the tricyclic variety) and even behavioural treatments might result in a worthwhile improvement of symptoms.
Similar articles
-
The overlap between IBS and IBD: what is it and what does it mean?Expert Rev Gastroenterol Hepatol. 2014 Feb;8(2):139-45. doi: 10.1586/17474124.2014.876361. Expert Rev Gastroenterol Hepatol. 2014. PMID: 24417262 Review.
-
The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?Clin Gastroenterol Hepatol. 2006 May;4(5):614-20. doi: 10.1016/j.cgh.2006.03.003. Epub 2006 Apr 17. Clin Gastroenterol Hepatol. 2006. PMID: 16630762
-
How can IBD be distinguished from IBS?Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S152-4. doi: 10.1002/ibd.20696. Inflamm Bowel Dis. 2008. PMID: 18816655 No abstract available.
-
Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease.World J Gastroenterol. 2017 May 14;23(18):3356-3366. doi: 10.3748/wjg.v23.i18.3356. World J Gastroenterol. 2017. PMID: 28566897 Free PMC article. Clinical Trial.
-
IBS and IBD - separate entities or on a spectrum?Nat Rev Gastroenterol Hepatol. 2016 Sep 26;13(10):613-21. doi: 10.1038/nrgastro.2016.141. Nat Rev Gastroenterol Hepatol. 2016. PMID: 27667579 Review.
Cited by
-
Functional gastrointestinal disorders in inflammatory bowel disease: Time for a paradigm shift?World J Gastroenterol. 2020 Jul 14;26(26):3712-3719. doi: 10.3748/wjg.v26.i26.3712. World J Gastroenterol. 2020. PMID: 32774052 Free PMC article. Review.
-
Tricyclic antidepressants for management of residual symptoms in inflammatory bowel disease.J Clin Gastroenterol. 2014 May-Jun;48(5):423-9. doi: 10.1097/MCG.0000000000000049. J Clin Gastroenterol. 2014. PMID: 24406434 Free PMC article.
-
Inflammatory bowel diseases: Current problems and future tasks.World J Gastrointest Pharmacol Ther. 2014 Aug 6;5(3):169-74. doi: 10.4292/wjgpt.v5.i3.169. World J Gastrointest Pharmacol Ther. 2014. PMID: 25133045 Free PMC article. Review.
-
Diagnosis and management of functional symptoms in inflammatory bowel disease in remission.World J Gastrointest Pharmacol Ther. 2016 Feb 6;7(1):78-90. doi: 10.4292/wjgpt.v7.i1.78. World J Gastrointest Pharmacol Ther. 2016. PMID: 26855814 Free PMC article. Review.
-
The Brain-Gut Axis: Psychological Functioning and Inflammatory Bowel Diseases.J Clin Med. 2021 Jan 20;10(3):377. doi: 10.3390/jcm10030377. J Clin Med. 2021. PMID: 33498197 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources